X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (689) 689
Newsletter (92) 92
Publication (35) 35
Book Review (14) 14
Book Chapter (9) 9
Newspaper Article (7) 7
Reference (3) 3
Magazine Article (2) 2
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
fumaric acid (449) 449
index medicus (309) 309
humans (289) 289
psoriasis (267) 267
dermatology (214) 214
fumaric-acid esters (188) 188
esters (184) 184
multiple sclerosis (146) 146
dimethyl fumarate (140) 140
female (116) 116
male (116) 116
research (107) 107
psoriasis - drug therapy (106) 106
fumaric acid esters (99) 99
double-blind (97) 97
animals (94) 94
analysis (86) 86
fumarates - therapeutic use (84) 84
drug therapy (82) 82
middle aged (81) 81
dermatologic agents (79) 79
formulae, receipts, prescriptions (79) 79
adult (76) 76
therapy (73) 73
treatment outcome (71) 71
pharmacology & pharmacy (66) 66
fumaric-acid (64) 64
oxidative stress (61) 61
neurosciences (57) 57
clinical neurology (54) 54
fumarates - pharmacology (53) 53
immunosuppressive agents - therapeutic use (53) 53
experimental autoimmune encephalomyelitis (51) 51
inflammation (49) 49
multiple-sclerosis (49) 49
aged (48) 48
care and treatment (48) 48
placebo-controlled phase-3 (48) 48
dermatologic agents - therapeutic use (47) 47
fumarates - administration & dosage (47) 47
administration, oral (46) 46
chemistry (44) 44
acids (43) 43
efficacy (43) 43
medicine & public health (43) 43
reports (43) 43
dimethylfumarate (42) 42
methotrexate (42) 42
mice (42) 42
placebo-controlled trial (42) 42
fumarates - adverse effects (40) 40
fumarsäure (40) 40
multicenter (40) 40
multiple sclerosis - drug therapy (40) 40
safety (38) 38
nrf2 (36) 36
adolescent (35) 35
derivatives (35) 35
biochemistry & molecular biology (33) 33
expression (33) 33
neurology (33) 33
skin (33) 33
immunology (32) 32
dermatologic agents - administration & dosage (31) 31
enzymes (31) 31
health aspects (31) 31
medical research (31) 31
antioxidants (30) 30
nf-kappa-b (29) 29
progressive multifocal leukoencephalopathy (29) 29
chemistry, multidisciplinary (28) 28
fermentation (28) 28
monomethylfumarate (28) 28
polymer science (28) 28
biotechnology & applied microbiology (27) 27
clinical trials (27) 27
dermatologic agents - adverse effects (27) 27
medicine, experimental (27) 27
activation (26) 26
chronic plaque psoriasis (26) 26
metabolism (26) 26
universities and colleges (26) 26
central-nervous-system (25) 25
cytokines (25) 25
fingolimod (25) 25
in-vitro (25) 25
maleic acid (25) 25
oral bg-12 (25) 25
proteins (25) 25
risk factors (25) 25
young adult (25) 25
cells, cultured (24) 24
polymers (24) 24
quality-of-life (24) 24
retrospective studies (24) 24
immunosuppressive agents - administration & dosage (23) 23
intellectual property (23) 23
nf-e2-related factor 2 - metabolism (23) 23
prospective studies (23) 23
review (23) 23
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (758) 758
German (39) 39
Chinese (3) 3
Japanese (2) 2
Spanish (2) 2
French (1) 1
Polish (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Trends in Pharmacological Sciences, ISSN 0165-6147, 01/2018, Volume 39, Issue 1, pp. 1 - 12
Fumaric acid ester-based drugs are used for the treatment of psoriasis and multiple sclerosis. All licensed fumaric acid ester drugs contain dimethylfumarate... 
NICOTINIC-ACID | DENDRITIC CELL-DIFFERENTIATION | MULTIPLE-SCLEROSIS | NRF2 | PROTEIN-COUPLED RECEPTOR | PLACEBO-CONTROLLED PHASE-3 | PHARMACOLOGY & PHARMACY | DIMETHYL FUMARATE | ORAL BG-12 | PSORIASIS | HUMAN T-CELLS | Fumaric acid | Esters
Journal Article
Dermatology, ISSN 1018-8665, 01/2018, Volume 233, Issue 4, pp. 295 - 302
Background: Fumaric acid esters (FAEs) are a broadly used therapy option for patients suffering from moderate-to-severe plaque psoriasis. Various studies in... 
Original Paper | Lymphopenia | Psoriasis | T cells | Fumaric acid esters | CD4+ and CD8+ cells | METABOLIC SYNDROME | CYTOKINES | EFFICACY | MANIFESTATION | CD8+cells | DIMETHYL FUMARATE | PML | DERMATOLOGY | CD4 | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | PATIENT | FUMADERM(R) | PSORIASIS PATIENTS
Journal Article
Journal of Neurotrauma, ISSN 0897-7151, 11/2017, Volume 34, Issue 21, pp. 327 - 3040
Journal Article
Neuroscience Letters, ISSN 0304-3940, 10/2013, Volume 555, pp. 165 - 170
Journal Article
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 10/2017, Volume 177, Issue 4, pp. 1024 - 1032
Summary Background Secukinumab is a fully human antibody that neutralizes interleukin‐17A. It has significant efficacy and a favourable safety profile in... 
DOUBLE-BLIND | PHASE-II | THERAPY | EFFICACY | SAFETY | DERMATOLOGY | Viral antibodies | Care and treatment | Interleukins | Fumaric acid | Clinical trials | Antibodies | Esters | Arthritis | Etanercept | Psoriasis | Skin | Patients
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 03/2018, Volume 178, Issue 3, pp. 586 - 587
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2013, Volume 8, Issue 10, p. e76670
Fumaric acid esters (FAE) are oral analogs of fumarate that have recently been shown to decrease relapse rate and disease progression in multiple sclerosis... 
CELLS | ACTIVATION | ANGIOGENESIS | MULTIDISCIPLINARY SCIENCES | DEGRADATION | KAPPA-B | DIMETHYL FUMARATE | HYPOXIA | STRESS | ENDOTHELIAL GROWTH-FACTOR | DELIVERY | Superoxide Dismutase - genetics | Astrocytes - pathology | Male | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Vascular Endothelial Growth Factor A - agonists | Female | NF-E2-Related Factor 2 - genetics | Superoxide Dismutase - metabolism | Disease Models, Animal | Astrocytes - drug effects | Signal Transduction | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Amyotrophic Lateral Sclerosis - genetics | Cells, Cultured | Mice, Transgenic | Organ Specificity | Gene Expression Regulation - drug effects | Amyotrophic Lateral Sclerosis - pathology | Animals | Fumarates - pharmacology | NF-E2-Related Factor 2 - metabolism | Amyotrophic Lateral Sclerosis - metabolism | Mice | Mutation | Superoxide Dismutase-1 | Astrocytes - metabolism | Brain | Multiple sclerosis | Transcription factors | Stabilization | Central nervous system | Superoxide dismutase | Esters | Nervous system | Activation | Blood-brain barrier | Rodents | Penicillin | Vascular endothelial growth factor | Neurons | Astrocytes | Transgenic mice | Amyotrophic lateral sclerosis | Neurological diseases | Neurology | Inhibitors | Fumaric acid | Acids | Plasmids | Hypoxia | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 1, p. e16172
Journal Article